Evidence map›Paper›PMID 42351141›Full record

ArticleMalaria journal2026

Healthcare workers' knowledge and acceptance of the malaria vaccine in the Nanoro Health District of Burkina Faso: a cross-sectional study.

Jean-Vincent Lamien, Bérenger Kaboré, Karim Derra, Zanma Michaël John Compaoré, Guétawendé Job Wilfried Nassa, Aimé Parfait Korou Yaro, Bapouguini Raymond Gbangou, Raffaella Ravinetto, Halidou Tinto, Carine Dochez

Abstract read
In one paragraph

Article in Malaria journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jean-Vincent LamienInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro, Nanoro, Burkina Faso. dofindoubel@gmail.com.
Bérenger KaboréInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.
Karim DerraInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.
Zanma Michaël John CompaoréInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.
Guétawendé Job Wilfried NassaInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.
Aimé Parfait Korou YaroCentre Médical Urbain de Nanoro, Nanoro, Burkina Faso.
Bapouguini Raymond GbangouDistrict Sanitaire de Nanoro, Nanoro, Burkina Faso.
Raffaella RavinettoDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Halidou TintoInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.
Carine DochezDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn February 2024, Burkina Faso introduced the malaria vaccine RTS,S/AS01 into its Expanded Programme on Immunisation (EPI). For vaccination to be successful, an important criterion is its acceptance by the population. Healthcare workers (HCWs) are among the primary sources of information for caregivers when deciding whether to vaccinate their children or not. This study aimed to assess HCWs' knowledge and acceptance of the new malaria vaccine (MV) in the Nanoro Health District and to identify factors associated with MV acceptance within this group.

methodsWe conducted a cross-sectional study among HCWs from April to May 2025 in Nanoro (Burkina Faso), using an online questionnaire. All HCWs employed in the public or private health sectors of the Nanoro Health District at the time of data collection were eligible to participate, upon voluntary informed consent. The vaccine acceptance rate was expressed as the proportion of HCWs willing to vaccinate their children out of the total number of participants. Logistic regression was employed for both bivariate and multivariate analyses to test associations.

resultsTwo hundred fifty-seven (257) HCWs out of 340 eligible HCWs participated in the survey. The vaccine acceptance rate was 98.8%. Insufficient information about the vaccine was the primary reason for hesitancy. Twenty-two percent (22.6%) of the HCWs were unaware of the type of vaccine used in the district and had no knowledge of the vaccination schedule. More than half (58.0%) stated that they did not receive any training before the vaccine rollout. Willingness to recommend the vaccine and positive attitudes were associated with HCWs' willingness to vaccinate their children, although independent effects could not be confirmed. No links were found between vaccine acceptance and sociodemographic characteristics.

conclusionsMost HCWs were willing to vaccinate their children against malaria. However, few were hesitant due to insufficient information about the vaccine and more than one-fifth had limited knowledge about this specific vaccine. Training all HCWs on the MV (whether involved in EPI or not) and strengthening communication about it are essential to address concerns around the vaccine, and ensure sustained uptake in the community, thereby improving national vaccination coverage.

Indexed as

Health Knowledge, Attitudes, PracticeHealth PersonnelMalariaMalaria VaccinesVaccinationAdultBurkina FasoCross-Sectional StudiesFemaleHumansMaleMiddle AgedSurveys and QuestionnairesYoung AdultMalaria VaccinesAcceptanceAfricaBurkina FasoConfidenceHealthcare workersHesitancyMalariaNanoroVaccinationVaccine

Identifiers

PMID42351141
PMCPMC13560235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.